The alimentary tract implant market size has grown strongly in recent years. It will grow from $5.13 billion in 2025 to $5.49 billion in 2026 at a compound annual growth rate (CAGR) of 7%. The growth in the historic period can be attributed to rising obesity rates, growth in metabolic disorders, advancements in endoscopic surgery, demand for non-pharmaceutical treatments, healthcare infrastructure expansion.
The alimentary tract implant market size is expected to see strong growth in the next few years. It will grow to $7.12 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increase in diabetes management implants, minimally invasive procedure demand, innovation in implant materials, precision treatment approaches, aging population growth. Major trends in the forecast period include minimally invasive digestive implants, bariatric and metabolic implants, endoscopic implant procedures, neuromodulation for GI disorders, long-term implant biocompatibility.
The increasing prevalence of gastrointestinal disorders is expected to drive the growth of the alimentary tract implant market. Gastrointestinal disorders encompass a wide range of conditions affecting the digestive tract, including the stomach, intestines, and associated organs, causing symptoms such as pain, inflammation, obstruction, or impaired motility. This rise in gastrointestinal disorders is primarily attributed to poor dietary habits, particularly the increased consumption of processed and high-fat foods that disrupt gut microbiota balance and contribute to digestive dysfunction. Demand for alimentary tract implants is growing as the surge in gastrointestinal disorders encourages healthcare providers to adopt advanced implantable solutions for managing obesity, fecal incontinence, gastrointestinal obstruction, and other chronic digestive conditions. For example, in September 2025, the UK Health Security Agency (UKHSA), a UK-based government public health body, reported that England recorded a 27% increase in laboratory-confirmed Campylobacter infections, rising from 96.1 per 100,000 people in 2022 to 122 per 100,000 in 2024. Therefore, the rising prevalence of gastrointestinal disorders is fueling the growth of the alimentary tract implant market.
Key companies operating in the alimentary tract implant market are focusing on integrating advanced surgical processing and therapeutic implant technologies, such as minimally invasive endoscopic technology, to enhance treatment precision, patient safety, and recovery outcomes. Minimally invasive endoscopic technology is an advanced method that uses a flexible endoscope equipped with imaging and surgical tools to access and treat internal organs through natural body openings, enabling real-time visualization and intervention without external incisions. For instance, in December 2024, Boston Scientific, a US-based medical device manufacturer specializing in minimally invasive therapies, launched the Apollo ESG System and Orbera365 Intragastric Balloon System, both leveraging endoscopic technology for weight-loss and gastrointestinal procedures. These products feature innovations such as incision-free endoscopic access, real-time visualization, and durable biocompatible materials, providing effective bariatric treatment with shorter recovery times and minimal complications. Apollo ESG System and Orbera365 enhance clinical efficiency, patient comfort, and the long-term success of alimentary tract interventions.
In January 2024, Olympus Corporation, a Japan-based medical technology provider specializing in endoscopic and therapeutic solutions, acquired Taewoong Medical Co., Ltd. for $370 million. Through this acquisition, Olympus gained access to Taewoong’s advanced gastrointestinal (GI) metallic stent portfolio and manufacturing expertise, strengthening its EndoTherapy business and expanding its presence in the alimentary tract implant sector. Taewoong Medical, based in South Korea, is known for its Niti-S series of GI stents used in the biliary tract, esophagus, colon, and duodenum.
Major companies operating in the alimentary tract implant market are Medtronic Public Limited Company, Boston Scientific Corporation, Cook Group Incorporated, B. Braun Melsungen AG, Allurion Technologies Incorporated, ReShape Lifesciences Incorporated, Spatz Medical Limited, Hobbs Medical Incorporated, MICRO-TECH (Nanjing) Company Limited, M.I.Tech Company Limited, ELLA-CS s.r.o., BVM Medical Limited, EndoGastric Solutions Inc., EnteroMedics Inc., Inspire Medical Systems Inc., Coloplast A/S, Axonics Inc., Medica S.p.A., Taewoong Medical Co. Ltd., S&G Biotech Incorporated.
North America was the largest region in the alimentary tract implant market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the alimentary tract implant market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the alimentary tract implant market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the alimentary tract implant market by increasing costs of medical-grade metals, polymers, and electronic stimulation components. These effects are most notable in bariatric and neuromodulation implants manufactured in Asia-Pacific and Europe. While tariffs have raised procedural costs, they have also encouraged domestic production and innovation in cost-efficient implant designs.
The alimentary tract implant market research report is one of a series of new reports that provides alimentary tract implant market statistics, including alimentary tract implant industry global market size, regional shares, competitors with a alimentary tract implant market share, detailed alimentary tract implant market segments, market trends and opportunities, and any further data you may need to thrive in the alimentary tract implant industry. This alimentary tract implant market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An alimentary-tract implant is a medical device inserted into the digestive system to support, enhance, or modify its function. It is typically placed in areas such as the stomach or small intestine, where it can divert, restrict, or regulate the movement of food and digestive fluids, as well as their interaction with the intestinal lining. These implants play an important role in managing conditions such as obesity, diabetes, and malabsorption disorders by altering nutrient flow, digestion, or absorption in targeted ways.
The primary implant types of alimentary-tract implants include bariatric restriction and balloons, gastric electrical stimulation or neuromodulation, gastrointestinal (GI) stents or endoluminal scaffolds, and continence or anal sphincter implants. Bariatric restriction and balloons refer to implantable or temporary devices designed to limit stomach capacity and promote weight loss by reducing food intake in individuals with obesity. The different procedural approaches used include endoscopic or transoral, laparoscopic bariatric, open or revision surgery, and colorectal or perineal implantation. The key indications include obesity or metabolic control, motility disorders, gastrointestinal (GI) stricture or obstruction or leak management, and fecal incontinence or continence restoration.
The alimentary-tract implant market consists of sales of endoscopic suturing systems, intestinal liners, duodenal sleeves, fecal diversion devices, anastomotic devices, and gastric emptying regulators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The alimentary tract implant market size is expected to see strong growth in the next few years. It will grow to $7.12 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increase in diabetes management implants, minimally invasive procedure demand, innovation in implant materials, precision treatment approaches, aging population growth. Major trends in the forecast period include minimally invasive digestive implants, bariatric and metabolic implants, endoscopic implant procedures, neuromodulation for GI disorders, long-term implant biocompatibility.
The increasing prevalence of gastrointestinal disorders is expected to drive the growth of the alimentary tract implant market. Gastrointestinal disorders encompass a wide range of conditions affecting the digestive tract, including the stomach, intestines, and associated organs, causing symptoms such as pain, inflammation, obstruction, or impaired motility. This rise in gastrointestinal disorders is primarily attributed to poor dietary habits, particularly the increased consumption of processed and high-fat foods that disrupt gut microbiota balance and contribute to digestive dysfunction. Demand for alimentary tract implants is growing as the surge in gastrointestinal disorders encourages healthcare providers to adopt advanced implantable solutions for managing obesity, fecal incontinence, gastrointestinal obstruction, and other chronic digestive conditions. For example, in September 2025, the UK Health Security Agency (UKHSA), a UK-based government public health body, reported that England recorded a 27% increase in laboratory-confirmed Campylobacter infections, rising from 96.1 per 100,000 people in 2022 to 122 per 100,000 in 2024. Therefore, the rising prevalence of gastrointestinal disorders is fueling the growth of the alimentary tract implant market.
Key companies operating in the alimentary tract implant market are focusing on integrating advanced surgical processing and therapeutic implant technologies, such as minimally invasive endoscopic technology, to enhance treatment precision, patient safety, and recovery outcomes. Minimally invasive endoscopic technology is an advanced method that uses a flexible endoscope equipped with imaging and surgical tools to access and treat internal organs through natural body openings, enabling real-time visualization and intervention without external incisions. For instance, in December 2024, Boston Scientific, a US-based medical device manufacturer specializing in minimally invasive therapies, launched the Apollo ESG System and Orbera365 Intragastric Balloon System, both leveraging endoscopic technology for weight-loss and gastrointestinal procedures. These products feature innovations such as incision-free endoscopic access, real-time visualization, and durable biocompatible materials, providing effective bariatric treatment with shorter recovery times and minimal complications. Apollo ESG System and Orbera365 enhance clinical efficiency, patient comfort, and the long-term success of alimentary tract interventions.
In January 2024, Olympus Corporation, a Japan-based medical technology provider specializing in endoscopic and therapeutic solutions, acquired Taewoong Medical Co., Ltd. for $370 million. Through this acquisition, Olympus gained access to Taewoong’s advanced gastrointestinal (GI) metallic stent portfolio and manufacturing expertise, strengthening its EndoTherapy business and expanding its presence in the alimentary tract implant sector. Taewoong Medical, based in South Korea, is known for its Niti-S series of GI stents used in the biliary tract, esophagus, colon, and duodenum.
Major companies operating in the alimentary tract implant market are Medtronic Public Limited Company, Boston Scientific Corporation, Cook Group Incorporated, B. Braun Melsungen AG, Allurion Technologies Incorporated, ReShape Lifesciences Incorporated, Spatz Medical Limited, Hobbs Medical Incorporated, MICRO-TECH (Nanjing) Company Limited, M.I.Tech Company Limited, ELLA-CS s.r.o., BVM Medical Limited, EndoGastric Solutions Inc., EnteroMedics Inc., Inspire Medical Systems Inc., Coloplast A/S, Axonics Inc., Medica S.p.A., Taewoong Medical Co. Ltd., S&G Biotech Incorporated.
North America was the largest region in the alimentary tract implant market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the alimentary tract implant market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the alimentary tract implant market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the alimentary tract implant market by increasing costs of medical-grade metals, polymers, and electronic stimulation components. These effects are most notable in bariatric and neuromodulation implants manufactured in Asia-Pacific and Europe. While tariffs have raised procedural costs, they have also encouraged domestic production and innovation in cost-efficient implant designs.
The alimentary tract implant market research report is one of a series of new reports that provides alimentary tract implant market statistics, including alimentary tract implant industry global market size, regional shares, competitors with a alimentary tract implant market share, detailed alimentary tract implant market segments, market trends and opportunities, and any further data you may need to thrive in the alimentary tract implant industry. This alimentary tract implant market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An alimentary-tract implant is a medical device inserted into the digestive system to support, enhance, or modify its function. It is typically placed in areas such as the stomach or small intestine, where it can divert, restrict, or regulate the movement of food and digestive fluids, as well as their interaction with the intestinal lining. These implants play an important role in managing conditions such as obesity, diabetes, and malabsorption disorders by altering nutrient flow, digestion, or absorption in targeted ways.
The primary implant types of alimentary-tract implants include bariatric restriction and balloons, gastric electrical stimulation or neuromodulation, gastrointestinal (GI) stents or endoluminal scaffolds, and continence or anal sphincter implants. Bariatric restriction and balloons refer to implantable or temporary devices designed to limit stomach capacity and promote weight loss by reducing food intake in individuals with obesity. The different procedural approaches used include endoscopic or transoral, laparoscopic bariatric, open or revision surgery, and colorectal or perineal implantation. The key indications include obesity or metabolic control, motility disorders, gastrointestinal (GI) stricture or obstruction or leak management, and fecal incontinence or continence restoration.
The alimentary-tract implant market consists of sales of endoscopic suturing systems, intestinal liners, duodenal sleeves, fecal diversion devices, anastomotic devices, and gastric emptying regulators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Alimentary Tract Implant Market Characteristics
3. Alimentary Tract Implant Market Supply Chain Analysis
4. Global Alimentary Tract Implant Market Trends and Strategies
5. Alimentary Tract Implant Market Analysis of End Use Industries
7. Global Alimentary Tract Implant Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Alimentary Tract Implant Total Addressable Market (TAM) Analysis for the Market
9. Alimentary Tract Implant Market Segmentation
10. Alimentary Tract Implant Market Regional and Country Analysis
11. Asia-Pacific Alimentary Tract Implant Market
12. China Alimentary Tract Implant Market
13. India Alimentary Tract Implant Market
14. Japan Alimentary Tract Implant Market
15. Australia Alimentary Tract Implant Market
16. Indonesia Alimentary Tract Implant Market
17. South Korea Alimentary Tract Implant Market
18. Taiwan Alimentary Tract Implant Market
19. South East Asia Alimentary Tract Implant Market
20. Western Europe Alimentary Tract Implant Market
21. UK Alimentary Tract Implant Market
22. Germany Alimentary Tract Implant Market
23. France Alimentary Tract Implant Market
24. Italy Alimentary Tract Implant Market
25. Spain Alimentary Tract Implant Market
26. Eastern Europe Alimentary Tract Implant Market
27. Russia Alimentary Tract Implant Market
28. North America Alimentary Tract Implant Market
29. USA Alimentary Tract Implant Market
30. Canada Alimentary Tract Implant Market
31. South America Alimentary Tract Implant Market
32. Brazil Alimentary Tract Implant Market
33. Middle East Alimentary Tract Implant Market
34. Africa Alimentary Tract Implant Market
36. Alimentary Tract Implant Market Competitive Landscape and Company Profiles
37. Alimentary Tract Implant Market Other Major and Innovative Companies
40. Alimentary Tract Implant Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Alimentary Tract Implant Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses alimentary tract implant market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for alimentary tract implant? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The alimentary tract implant market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Implant Type: Bariatric Restriction And Balloons; Gastric Electrical Stimulation Or Neuromodulation; Gastrointestinal (GI) Stents Or Endoluminal Scaffolds; Continence Or Anal Sphincter Implants2) By Procedure Approach: Endoscopic Or Transoral; Laparoscopic Bariatric; Open Or Revision Surgery; Colorectal Or Perineal Implantation
3) By Indication: Obesity Or Metabolic Control; Motility Disorders; Gastrointestinal (GI) Stricture Or Obstruction Or Leak Management; Fecal Incontinence Or Continence Restoration
Subsegments:
1) By Bariatric Restriction And Balloons: Gastric Bands; Gastric Balloons; Adjustable Gastric Balloons; Non-Adjustable Gastric Balloons; Intragastric Balloons2) By Gastric Electrical Stimulation Or Neuromodulation: Implantable Gastric Stimulators; Vagal Nerve Stimulators; Enteric Nerve Stimulators; Gastric Pacemakers
3) By Gastrointestinal Stents Or Endoluminal Scaffolds: Esophageal Stents; Gastric Stents; Duodenal Stents; Colonic Stents; Biliary Stents
4) By Continence Or Anal Sphincter Implants: Artificial Anal Sphincters; Sacral Nerve Stimulators; Magnetic Anal Sphincters
Companies Mentioned: Medtronic Public Limited Company; Boston Scientific Corporation; Cook Group Incorporated; B. Braun Melsungen AG; Allurion Technologies Incorporated; ReShape Lifesciences Incorporated; Spatz Medical Limited; Hobbs Medical Incorporated; MICRO-TECH (Nanjing) Company Limited; M.I.Tech Company Limited; ELLA-CS s.r.o.; BVM Medical Limited; EndoGastric Solutions Inc.; EnteroMedics Inc.; Inspire Medical Systems Inc.; Coloplast A/S; Axonics Inc.; Medica S.p.A.; Taewoong Medical Co. Ltd.; S&G Biotech Incorporated
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Alimentary Tract Implant market report include:- Medtronic Public Limited Company
- Boston Scientific Corporation
- Cook Group Incorporated
- B. Braun Melsungen AG
- Allurion Technologies Incorporated
- ReShape Lifesciences Incorporated
- Spatz Medical Limited
- Hobbs Medical Incorporated
- MICRO-TECH (Nanjing) Company Limited
- M.I.Tech Company Limited
- ELLA-CS s.r.o.
- BVM Medical Limited
- EndoGastric Solutions Inc.
- EnteroMedics Inc.
- Inspire Medical Systems Inc.
- Coloplast A/S
- Axonics Inc.
- Medica S.p.A.
- Taewoong Medical Co. Ltd.
- S&G Biotech Incorporated
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.49 Billion |
| Forecasted Market Value ( USD | $ 7.12 Billion |
| Compound Annual Growth Rate | 6.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
